Page last updated: 2024-10-16

aminolevulinic acid and Cardiotoxicity

aminolevulinic acid has been researched along with Cardiotoxicity in 1 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Cardiotoxicity: Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abe, K1
Ikeda, M1
Ide, T1
Tadokoro, T1
Miyamoto, HD1
Furusawa, S1
Tsutsui, Y1
Miyake, R1
Ishimaru, K1
Watanabe, M1
Matsushima, S1
Koumura, T1
Yamada, KI1
Imai, H1
Tsutsui, H1

Other Studies

1 other study available for aminolevulinic acid and Cardiotoxicity

ArticleYear
Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
    Science signaling, 2022, Volume: 15, Issue:758

    Topics: Aminolevulinic Acid; Animals; Cardiotoxicity; DNA, Mitochondrial; Doxorubicin; Ferroptosis; Heme; Ir

2022